Adverse Events Following Misoprostol Induction of Labor
Off-label use of misoprostol (Cytotec) for labor induction has been steadily increasing for 10 years, even though this use is approved neither by the U.S. [FDA], other national drug regulatory agencies, the pharmaceutical industry, the Cochrane Library nor a number of national obstetric organizations Read more…. Adverse Events Following Misoprostol Induction of Labor